Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing Local Product Insert

Full Prescribing Info

Indications/Uses

Xpreza 100 is indicated for treatment of patients with the following myelodysplastic syndrome subtypes: Refractory anaemia (RA); Refractory anaemia with ringed sideroblasts (if accompanied by neutropenia or thrombocytopenia or requiring transfusions; Refractory anemia with excess blasts; Refractory anemia with excess blasts in transformation (or acute myeloid leukemia with 20-30% bone marrow blasts and multi-lineage dysplasia, according to World Health Organisation (WHO) classification); Adult patients aged 65 years or older who are not eligible for haematopoietic stem cell transplantation (HSCT with AML with >30% marrow blasts according to the WHO classification; Chronic myelomonocytic leukemia.

Xpreza 100 Indications/Uses

azacitidine

Manufacturer:

Natco Pharma

Distributor:

Atlanta Medicare